1. Home
  2. BSRR vs TRDA Comparison

BSRR vs TRDA Comparison

Compare BSRR & TRDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sierra Bancorp

BSRR

Sierra Bancorp

HOLD

Current Price

$36.25

Market Cap

418.8M

Sector

Finance

ML Signal

HOLD

TRDA

Entrada Therapeutics Inc.

HOLD

Current Price

$11.78

Market Cap

404.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BSRR
TRDA
Founded
1977
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
418.8M
404.4M
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
BSRR
TRDA
Price
$36.25
$11.78
Analyst Decision
Buy
Strong Buy
Analyst Count
2
1
Target Price
$38.50
$20.00
AVG Volume (30 Days)
75.0K
254.1K
Earning Date
02-02-2026
02-26-2026
Dividend Yield
2.82%
N/A
EPS Growth
10.28
N/A
EPS
3.11
N/A
Revenue
$149,180,000.00
$61,520,000.00
Revenue This Year
$11.13
N/A
Revenue Next Year
$3.58
$3.14
P/E Ratio
$11.86
N/A
Revenue Growth
1.65
N/A
52 Week Low
$22.42
$4.93
52 Week High
$38.46
$14.27

Technical Indicators

Market Signals
Indicator
BSRR
TRDA
Relative Strength Index (RSI) 64.55 61.20
Support Level $32.96 $11.28
Resistance Level $36.79 $11.82
Average True Range (ATR) 1.51 0.71
MACD 0.13 0.06
Stochastic Oscillator 71.58 82.19

Price Performance

Historical Comparison
BSRR
TRDA

About BSRR Sierra Bancorp

Sierra Bancorp is a California-based bank holding company, which offers a range of retail and commercial banking services. it offers a wide range of deposit products and services for individuals and businesses including checking accounts, savings accounts, money market demand accounts, time deposits, retirement accounts, and sweep accounts. The company's lending activities cover real estate, commercial (including small business), mortgage warehouse, agricultural and consumer loans, and also offers commercial construction loans and multifamily and agricultural credit facilities among other types of real estate loans.

About TRDA Entrada Therapeutics Inc.

Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company. It aims to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient intracellular delivery into a variety of organs and tissues, resulting in an improved therapeutic index and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others. Its oligonucleotide programs are in development for the potential treatment of people living with Duchenne, which are exon 44, 45, 50, and 51 skipping amenable. It has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1.

Share on Social Networks: